These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27102512)

  • 21. Diabetic dyslipidemia and the heart.
    Vasudevan AR; Garber AJ
    Heart Fail Clin; 2006 Jan; 2(1):37-52. PubMed ID: 17386875
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
    Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
    J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of diagnosing NASH - could a simple blood test be the key?
    Francque S; Vonghia L
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):995-997. PubMed ID: 28862886
    [No Abstract]   [Full Text] [Related]  

  • 24. Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease.
    Byrne CD; Targher G
    Gastroenterology; 2016 Jan; 150(1):7-10. PubMed ID: 26602219
    [No Abstract]   [Full Text] [Related]  

  • 25. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
    [No Abstract]   [Full Text] [Related]  

  • 26. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease.
    Elsheikh E; Younoszai Z; Otgonsuren M; Hunt S; Raybuck B; Younossi ZM
    J Gastroenterol Hepatol; 2014; 29(7):1528-34. PubMed ID: 25587619
    [No Abstract]   [Full Text] [Related]  

  • 27. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Mathurin P; Nagy LA
    Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520
    [No Abstract]   [Full Text] [Related]  

  • 28. The association between primary bacteremia of presumed gastrointestinal origin and nonalcoholic fatty liver disease.
    Nseir W; Artul S; Nasrallah N; Mahamid M
    Dig Liver Dis; 2016 Mar; 48(3):343-4. PubMed ID: 26534773
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease.
    Filipović B; Forbes A; Tepeš B; Dumitraşcu DL
    Can J Gastroenterol Hepatol; 2018; 2018():2097435. PubMed ID: 30155450
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic.
    Bernstein DE
    Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing.
    Emrich T; Schattenberg JM
    Aliment Pharmacol Ther; 2021 Jul; 54(2):214-215. PubMed ID: 34170537
    [No Abstract]   [Full Text] [Related]  

  • 32. [Non alcoholic fatty liver: a growing epidemic].
    Montes Teves P
    Rev Gastroenterol Peru; 2016; 36(3):195-196. PubMed ID: 27716754
    [No Abstract]   [Full Text] [Related]  

  • 33. [Not Available].
    Ostendorf GM
    Versicherungsmedizin; 2016 Jun; 69(2):79-80. PubMed ID: 27483691
    [No Abstract]   [Full Text] [Related]  

  • 34. Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.
    Mantovani A; Grani G
    Dig Dis Sci; 2018 Jul; 63(7):1970-1976. PubMed ID: 29675665
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease is associated with subclinical coronary artery disease in otherwise healthy individuals.
    Wong MYZ; Yap JJL; Cheah MCC; Goh GBB; Yeo KK
    Ann Acad Med Singap; 2021 Jun; 50(6):500-502. PubMed ID: 34195761
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between psoriasis and non-alcoholic fatty liver disease - Updated systematic review and adjusted meta-analysis.
    Phan K; Onggo J; Charlton O; Smith SD
    Australas J Dermatol; 2019 Nov; 60(4):e352-e355. PubMed ID: 30906989
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonalcoholic Fatty Liver Disease.
    Gaglio PJ
    Clin Liver Dis; 2016 May; 20(2):xiii-xiv. PubMed ID: 27063278
    [No Abstract]   [Full Text] [Related]  

  • 38. Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population.
    Xu X; Alanaeme J; Wen Y; Colantonio LD; Muntner P; Long MT
    Gastroenterology; 2023 Apr; 164(4):688-689.e4. PubMed ID: 36623777
    [No Abstract]   [Full Text] [Related]  

  • 39. The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemic.
    Mrad RA; Merjaneh N; Mubarak G; Lopez R; Zein NN; Alkhouri N
    Hepatology; 2016 Oct; 64(4):1386-7. PubMed ID: 26991537
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?].
    Volkova NI; Porksheyan MI
    Ter Arkh; 2017; 89(2):91-98. PubMed ID: 28393828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.